LAGUNA HILLS, Calif., Nov. 28, 2018 /PRNewswire/ — Adagio Medical, Inc., developer of the iCLAS™ technology, the company’s ultra-low temperature intelligent continuous lesion ablation system for the treatment of cardiac arrhythmias, announces updates to its ongoing cryoablation study for Persistent Atrial Fibrillation (PsAF). The study is currently being conducted at two clinical sites […]
Other News
Canon Medical’s Ultrasound Detail and Industry-Leading Depth Make It Easier for Clinicians to Image a Wide Range of Patients
CHICAGO–(BUSINESS WIRE)–Canon Medical Systems USA, Inc. is showcasing its premium Aplio™ i-series ultrasound platform with the deepest penetration available on the market at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, November 25 – 30, 2018 (Booth #1938, South Level 3). The Aplio i-series platform, a highly advanced and scalable […]
Resverlogix Announces Publication on Apabetalone in Atherosclerosis Journal
CALGARY, Alberta, Nov. 28, 2018 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announced today the recent publication of an article titled: “Apabetalone downregulates factors and pathways associated with vascular calcification” in Atherosclerosis, the official peer-reviewed scientific journal of the European Atherosclerosis Society. “Apabetalone and its unique mechanism […]
InspireMD Announces Regulatory and Reimbursement Approval of CGuard™ Embolic Prevention System in Australia
TEL AVIV, Israel, Nov. 28, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that its novel CGuard™ Embolic Prevention System (EPS) has been granted regulatory approval […]
Medical Leaders Join BioSig Clinical Advisory Board
Santa Monica, CA, Nov. 28, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company formed a Clinical Advisory Board to complement existing scientific […]
Carson S. Webb, MD Joins Alaska Heart & Vascular Institute
ANCHORAGE, Alaska, Nov. 27, 2018 /PRNewswire/ — Alaska Heart & Vascular Institute (AHVI) is pleased to announce the addition of Carson S. Webb, M.D. to the Mat-Su clinic in Palmer, AK. Dr. Webb graduated with a degree in medicine from the University of South Alabama in 2000. He specializes in percutaneous coronary, peripheral arterial, and peripheral venous interventions. […]
Amarin Announces Proposed Public Offering of American Depositary Shares
BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 26, 2018 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) today announced a registered underwritten public offering of its American Depositary Shares (“ADSs”). All of the shares in the proposed offering are to be sold by Amarin. The offering is subject to market conditions, […]
BioSig Technologies Signs Agreement with Texas Cardiac Arrhythmia Institute for First–in-Human Studies
Santa Monica, CA, Nov. 27, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has signed an agreement with Texas Cardiac Arrhythmia […]
Innovative Health Receives FDA Clearances to Reprocess St. Jude Medical’s Advisor™ FL, Two Medtronic Diagnostic Catheters and Biosense Webster’s DECANAV®.
PHOENIX–(BUSINESS WIRE)–Innovative Health, a national leader in medical device reprocessing for the cardiology sector, announced it has received FDA clearances to reprocess the Advisor FL Circular Mapping Catheter, Medtronic’s Torqr™ and Marinr™, and Biosense Webster’s DECANAV. Three of these clearances were received within the last month alone. Innovative Health has already […]
Stereotaxis to Present at the 11th Annual LD Micro Main Event Investor Conference
ST. LOUIS, Nov. 26, 2018 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David Fischel, Chairman and Chief Executive Officer, is scheduled to present at the 11th Annual LD Micro Main Event investor conference. Mr. Fischel […]
Recent
BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure
Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease
Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging
Popular
- No commented posts yet